Pineapple Express Cannabis (PNXP) Cash from Investing Activities (2018 - 2025)

Pineapple Express Cannabis' (PNXP) quarterly Cash from Investing Activities came in at -$190000.0 in Q2 2025, down 465.93% quarter-over-quarter from $51922.0 in Q1 2021.

Pineapple Express Cannabis (PNXP) Cash from Investing Activities (2018 - 2025) Analysis & Trends

Pineapple Express Cannabis has disclosed Cash from Investing Activities across 5 years of filings, most recently posting -$190000.0 for Q2 2025.

  • Cash from Investing Activities for Q2 2025 came in at -$190000.0, changed N/A year-over-year; the trailing twelve-month figure through Oct 2025 was -$190000.0 (down 465.93% YoY), and the FY2021 annual result was $30251.0, up 329.89% from the prior year.
  • Cash from Investing Activities came in at -$190000.0 for Q2 2025 at Pineapple Express Cannabis, down from $51922.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $51922.0 in Q1 2021 to a low of -$190000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Pineapple Express Cannabis - - - -

Historic Data

Download Data
DateValue
Apr 30, 2025 -190,000.00
Apr 30, 2025 -190,000.00
Jan 31, 2021 51,922.00
Jan 31, 2021 51,922.00
Oct 31, 2020 -8,091.00
Oct 31, 2020 -8,091.00
Jan 31, 2020 -9,609.00
Jan 31, 2020 -9,609.00
Oct 31, 2019 -3,550.00
Oct 31, 2019 -3,550.00
Jan 31, 2018 -1,155.00
Jan 31, 2018 -1,155.00